首 页
医药产品
医保药品
中标目录
医药招标
数据中心
医学资料
医药新闻
医药展会
OTC药品
保健品
医疗器械
处方药
专科药
中医药
器械中标目录
药品批发行情
求购信息
医药下载
药价简讯
当前位置:药药网 / 药品 / 美国NDC未完成药物数据库文件(本栏目收费,不能显示细节,电话13136136841)
药品名称:
商品名称:
药品NDC:
上市日期:
-
格式:2020-5-3
注册申请号:
市场分类:
不限
ANDA
BLA
NDA
EMERGENCY USE AUTHORIZATION
NDA AUTHORIZED GENERIC
OTC MONOGRAPH FINAL
OTC MONOGRAPH NOT FINAL
UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE
UNAPPROVED DRUG OTHER
UNAPPROVED HOMEOPATHIC
UNAPPROVED MEDICAL GAS
活性成分:
持证企业:
美国药品NDC(国家药品编码)与药品说明书数据库
美国NDC未完成药物数据库文件
美国NDC复合药物数据库文件
美国NDC数据库排除药物数据库文件
 美国NDC未完成药物数据库文件19583条(本栏目收费,不能显示细节,电话13136136841)
药品名称(分析)
商品名
药品NDC
专利人(分析)
上市日期
活性成分
市场分类
规格(分析)
申请号
Colfosceril Palmitate
BULK INGREDIENT
0441-0726
Sigma-Aldrich Corporation
1998/9/1 0:00:00
COLFOSCERI
BULK INGREDIENT
1
0441-0726_
Colfosceril Palmitate
BULK INGREDIENT
0441-0726
Sigma-Aldrich Corporation
1998/9/1 0:00:00
COLFOSCERI
BULK INGREDIENT
1
0441-0726_
Tripalmitin
BULK INGREDIENT
0441-0904
Sigma-Aldrich Corporation
1985/12/23 0:00:00
TRIPALMITI
BULK INGREDIENT
1
0441-0904_
Ferumoxytol Drug Substance
BULK INGREDIENT
0441-1521
Sigma-Aldrich Corporation
2010/10/19 0:00:00
FERUMOXYTO
BULK INGREDIENT
200
0441-1521_
belantamab mafodotin
BULK INGREDIENT
0441-2397
Sigma-Aldrich Corporation
2020/8/5 0:00:00
BELANTAMAB
DRUG FOR FURTHER PROCESSING
60
0441-2397_
Inosine
BULK INGREDIENT
0441-2770
Sigma-Aldrich Corporation
2014/9/24 0:00:00
INOSINE
BULK INGREDIENT
3
0441-2770_
Adenine
BULK INGREDIENT
0441-2894
Sigma-Aldrich Corporation
2009/9/1 0:00:00
ADENINE
BULK INGREDIENT
1
0441-2894_
Glatiramer Acetate
BULK INGREDIENT
0441-3642
Sigma-Aldrich Corporation
2015/4/16 0:00:00
GLATIRAMER
BULK INGREDIENT
1
0441-3642_
vilazodone hydrochloride
DRUG FOR FURTHER PROCESSING
0456-1111
Allergan, Inc.
2011/4/29 0:00:00
VILAZODONE
DRUG FOR FURTHER PROCESSING
10
0456-1111_
vilazodone hydrochloride
DRUG FOR FURTHER PROCESSING
0456-1121
Allergan, Inc.
2011/4/29 0:00:00
VILAZODONE
DRUG FOR FURTHER PROCESSING
20
0456-1121_
vilazodone hydrochloride
DRUG FOR FURTHER PROCESSING
0456-1141
Allergan, Inc.
2011/4/29 0:00:00
VILAZODONE
DRUG FOR FURTHER PROCESSING
40
0456-1141_
linaclotide
DRUG FOR FURTHER PROCESSING
0456-1204
Allergan, Inc.
2012/9/8 0:00:00
LINACLOTID
DRUG FOR FURTHER PROCESSING
145
0456-1204_
linaclotide
DRUG FOR FURTHER PROCESSING
0456-1205
Allergan, Inc.
2012/9/8 0:00:00
LINACLOTID
DRUG FOR FURTHER PROCESSING
290
0456-1205_
linaclotide
DRUG FOR FURTHER PROCESSING
0456-1206
Allergan, Inc.
2017/1/30 0:00:00
LINACLOTID
DRUG FOR FURTHER PROCESSING
72
0456-1206_
memantine hydrochloride and donepezil hydrochloride
DRUG FOR FURTHER PROCESSING
0456-1208
Allergan, Inc.
2016/7/18 0:00:00
DONEPEZIL
DRUG FOR FURTHER PROCESSING
0456-1208_
memantine hydrochloride and donepezil hydrochloride
DRUG FOR FURTHER PROCESSING
0456-1215
Allergan, Inc.
2014/12/24 0:00:00
DONEPEZIL
DRUG FOR FURTHER PROCESSING
0456-1215_
memantine hydrochloride and donepezil hydrochloride
DRUG FOR FURTHER PROCESSING
0456-1222
Allergan, Inc.
2016/7/18 0:00:00
DONEPEZIL
DRUG FOR FURTHER PROCESSING
0456-1222_
memantine hydrochloride and donepezil hydrochloride
DRUG FOR FURTHER PROCESSING
0456-1238
Allergan, Inc.
2014/12/24 0:00:00
DONEPEZIL
DRUG FOR FURTHER PROCESSING
0456-1238_
nebivolol hydrochloride
DRUG FOR FURTHER PROCESSING
0456-1403
Allergan, Inc.
2008/1/22 0:00:00
NEBIVOLOL
DRUG FOR FURTHER PROCESSING
2.5
0456-1403_
nebivolol hydrochloride
DRUG FOR FURTHER PROCESSING
0456-1406
Allergan, Inc.
2008/1/22 0:00:00
NEBIVOLOL
DRUG FOR FURTHER PROCESSING
5
0456-1406_
首页
(current)
31
(current)
32
(current)
33
(current)
34
(current)
35
(current)
36
(current)
37
(current)
38
(current)
39
(current)
40
(current)
(current)
末页
(current)
网站地图
-
网站开发
-
网站简介
-
会员服务
-
法律声明
-
联系我们
-
药品招商频道
-
药品信息排行
-
2018年版国家基本药物目录
-
意见反馈
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:
医药研究数据
|
医药资料
|
SDA药品评审中心
|
中医网
|
中药处方系统
|
爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究 客服热线:0575-83552251 / 13754370441 QQ客服:
浙ICP备16010490号-2
增值电信业务经营许可证:
浙B2-20220931
互联网药品信息服务资格证书编号:
(浙)-经营性2023-0215
浙公网安备:330683240604819103159
医药代理商群1:
医药代理商群2:
医药代理商群3: